Norton Rose wins plum role on $2.5bn Nestle buy-out of Novartis' nutrition arm
Norton Rose has landed a role on Nestle's $2.5bn (£1.3bn) acquisition of the nutrition arm of pharmaceutical giant Novartis.
January 17, 2007 at 07:12 PM
2 minute read
Norton Rose has landed a role on Nestle's $2.5bn (£1.3bn) acquisition of the nutrition arm of pharmaceuticals giant Novartis.
The instruction is the firm's biggest-ever for the client and comes after it was appointed to Nestle's panel for European M&A in 2003.
London corporate partner Campbell Steedman led the Norton Rose team for Nestle. The firm was first instructed on the deal in October 2005. Steedman was assisted by London corporate partner Phil Mellor and employment partner Cornelia Marquardt.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Trending Stories
- 1First Lawsuit Filed Alleging Contraceptive Depo-Provera Caused Brain Tumor
- 2BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 3The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 4The Growing Tension—And Opportunity—in Big Law Nonequity Tiers
- 5The 'Biden Effect' on Senior Attorneys: Should I Stay or Should I Go?
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
